Abisambra, J.F., Jinwal, U.K., Jones, J.R., Blair, L.J., Koren, J., 3rd, and Dickey, C.A. (2011). Exploiting the diversity of the heat-shock protein family for primary and secondary tauopathy therapeutics. Curr
Neuropharmacol 9, 623-631.
Abisambra, J.F., Jinwal, U.K., Suntharalingam, A., Arulselvam, K., Brady, S., Cockman, M., Jin, Y., Zhang, B., and Dickey, C.A. (2012).
DnaJA1 antagonizes constitutive Hsp70-mediated stabilization of tau. J Mol Biol 421, 653-661.
Avila, M.F., Cabezas, R., Torrente, D., Gonzalez, J., Morales, L., Alvarez, L., Capani, F., and Barreto, G.E. (2013). Novel interactions of GRP78:
UPR and estrogen responses in the brain. Cell Biol Int 37, 521-532.
Berchtold, N.C., and Cotman, C.W. (1998). Evolution in the
conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol Aging 19, 173-189.
Bijur, G.N., and Jope, R.S. (2000). Opposing actions of
phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity. J Neurochem 75, 2401-2408.
Carter, D.B., and Chou, K.C. (1998). A model for structure-dependent binding of Congo red to Alzheimer beta-amyloid fibrils. Neurobiol Aging 19, 37-40.
Cohen, T., Frydman-Marom, A., Rechter, M., and Gazit, E. (2006).
Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives. Biochemistry 45, 4727-4735.
Dickey, C.A., Dunmore, J., Lu, B., Wang, J.W., Lee, W.C., Kamal, A., Burrows, F., Eckman, C., Hutton, M., and Petrucelli, L. (2006). HSP induction mediates selective clearance of tau phosphorylated at
proline-directed Ser/Thr sites but not KXGS (MARK) sites. FASEB J 20, 753-755.
34
Dickey, C.A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R.M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C.B., et al.
(2007). The high-affinity HSP90-CHIP complex recognizes and
selectively degrades phosphorylated tau client proteins. J Clin Invest 117, 648-658.
Dou, F., Netzer, W.J., Tanemura, K., Li, F., Hartl, F.U., Takashima, A., Gouras, G.K., Greengard, P., and Xu, H. (2003). Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci U S A 100, 721-726.
Drewes, G., Mandelkow, E.M., Baumann, K., Goris, J., Merlevede, W., and Mandelkow, E. (1993). Dephosphorylation of tau protein and
Alzheimer paired helical filaments by calcineurin and phosphatase-2A.
FEBS Lett 336, 425-432.
Fang, X.K., Gao, J., and Zhu, D.N. (2008). Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci 82, 615-622.
Forlenza, O.V., de Paula, V.J., Machado-Vieira, R., Diniz, B.S., and Gattaz, W.F. (2012). Does lithium prevent Alzheimer's disease? Drugs Aging 29, 335-342.
Forsyth, E., and Ritzline, P.D. (1998). An overview of the etiology, diagnosis, and treatment of Alzheimer disease. Phys Ther 78, 1325-1331.
Fratiglioni, L., Viitanen, M., von Strauss, E., Tontodonati, V., Herlitz, A., and Winblad, B. (1997). Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48, 132-138.
Fu, M., Deng, D., Huang, R., Zhang, N., Su, Z., and Qiu, S.X. (2013). A new flavanocoumarin from the root of Flemingia philippinensis. Nat Prod Res 27, 1237-1241.
Glenner, G.G., and Wong, C.W. (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120, 885-890.
35
Gorbenko, G.P., and Kinnunen, P.K. (2006). The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem Phys Lipids 141, 72-82.
Hasegawa, M., Smith, M.J., and Goedert, M. (1998). Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 437, 207-210.
Hong-Qi, Y., Zhi-Kun, S., and Sheng-Di, C. (2012). Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Abeta and tau. Transl Neurodegener 1, 21.
Isik, A.T. (2010). Late onset Alzheimer's disease in older people. Clin Interv Aging 5, 307-311.
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., and Ihara, Y. (1994). Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13, 45-53.
Khlistunova, I., Biernat, J., Wang, Y., Pickhardt, M., von Bergen, M., Gazova, Z., Mandelkow, E., and Mandelkow, E.M. (2006). Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J Biol Chem 281, 1205-1214.
Lee, V.M., Balin, B.J., Otvos, L., Jr., and Trojanowski, J.Q. (1991). A68:
a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251, 675-678.
Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buee, L., and Brion, J.P. (2007). Early
axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am J Pathol 171, 976-992.
Li, X., Kumar, Y., Zempel, H., Mandelkow, E.M., Biernat, J., and Mandelkow, E. (2011). Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration. EMBO J 30, 4825-4837.
36
Martin, C., Solis, L., Concha, M.I., and Otth, C. (2011). [Herpes simplex virus type 1 as risk factor associated to Alzheimer disease]. Rev Med Chil 139, 779-786.
Momeni, P., Pittman, A., Lashley, T., Vandrovcova, J., Malzer, E., Luk, C., Hulette, C., Lees, A., Revesz, T., Hardy, J., and de Silva, R. (2009).
Clinical and pathological features of an Alzheimer's disease patient with the MAPT Delta K280 mutation. Neurobiol Aging 30, 388-393.
Morshedi, D., Rezaei-Ghaleh, N., Ebrahim-Habibi, A., Ahmadian, S., and Nemat-Gorgani, M. (2007). Inhibition of amyloid fibrillation of lysozyme by indole derivatives--possible mechanism of action. FEBS J 274,
6415-6425.
Navarrete, L.P., Guzman, L., San Martin, A., Astudillo-Saavedra, L., and Maccioni, R.B. (2012). Molecules of the quinoline family block tau self-aggregation: implications toward a therapeutic approach for Alzheimer's disease. J Alzheimers Dis 29, 79-88.
Povova, J., Ambroz, P., Bar, M., Pavukova, V., Sery, O., Tomaskova, H., and Janout, V. (2012). Epidemiological of and risk factors for
Alzheimer's disease: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 156, 108-114.
Rubio-Perez, J.M., and Morillas-Ruiz, J.M. (2012). A review:
inflammatory process in Alzheimer's disease, role of cytokines.
ScientificWorldJournal 2012, 756357.
Sadqi, M., Hernandez, F., Pan, U., Perez, M., Schaeberle, M.D., Avila, J., and Munoz, V. (2002). Alpha-helix structure in Alzheimer's disease aggregates of tau-protein. Biochemistry 41, 7150-7155.
Sahara, N., Maeda, S., Yoshiike, Y., Mizoroki, T., Yamashita, S.,
Murayama, M., Park, J.M., Saito, Y., Murayama, S., and Takashima, A.
(2007). Molecular chaperone-mediated tau protein metabolism
counteracts the formation of granular tau oligomers in human brain. J Neurosci Res 85, 3098-3108.
37
Sarkar, M., Kuret, J., and Lee, G. (2008). Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone. J Neurosci Res 86, 2763-2773.
Siddique, H., Hynan, L.S., and Weiner, M.F. (2009). Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease. J Clin Psychiatry 70, 915-918.
Sisodia, S.S., and St George-Hyslop, P.H. (2002). gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?
Nat Rev Neurosci 3, 281-290.
Soto, C. (2003). Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4, 49-60.
Spillantini, M.G., and Goedert, M. (1998). Tau protein pathology in neurodegenerative diseases. Trends Neurosci 21, 428-433.
Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S., Iwatsubo, T.,
Goedert, M., and Hasegawa, M. (2005). Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem 280, 7614-7623.
Tjernberg, L.O., Callaway, D.J., Tjernberg, A., Hahne, S., Lilliehook, C., Terenius, L., Thyberg, J., and Nordstedt, C. (1999). A molecular model of Alzheimer amyloid beta-peptide fibril formation. J Biol Chem 274,
12619-12625.
von Bergen, M., Barghorn, S., Li, L., Marx, A., Biernat, J., Mandelkow, E.M., and Mandelkow, E. (2001). Mutations of tau protein in
frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem 276, 48165-48174.
von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E.M., and Mandelkow, E. (2000). Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif
((306)VQIVYK(311)) forming beta structure. Proc Natl Acad Sci U S A 97, 5129-5134.
38
Wenk, G.L. (2003). Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 64 Suppl 9, 7-10.
Wenk, G.L. (2006). Neuropathologic changes in Alzheimer's disease:
potential targets for treatment. J Clin Psychiatry 67 Suppl 3, 3-7; quiz 23.
Wolfe, M.S. (2009). Tau mutations in neurodegenerative diseases. J Biol Chem 284, 6021-6025.
Yoshida, J., Seino, H., Ito, Y., Nakano, T., Satoh, T., Ogane, Y., Suwa, S., Koshino, H., and Kimura, K. (2013). Inhibition of Glycogen Synthase Kinase-3beta by Falcarindiol Isolated from Japanese Parsley (Oenanthe javanica). J Agric Food Chem 61, 7515-7521.
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.M., Iwata, N., Saido, T.C., Maeda, J., Suhara, T., Trojanowski, J.Q., and Lee, V.M. (2007).
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337-351.
黃鉦翔 (2013). 以 amyloid-beta 聚集為目標的阿茲海默氏症治療策略.
國立臺灣師範大學生命科學系碩士論文.
39